Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc
(NQ:
VRCA
)
12.69
USD
-1.00 (-7.30%)
Official Closing Price
Updated: 7:57 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Verrica Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference
April 06, 2021
From
GlobeNewswire News Releases
Verrica Announces Election of Gary Goldenberg, MD, Verrica’s Chief Medical Officer, to Membership in the American Dermatological Association
March 29, 2021
From
GlobeNewswire News Releases
Verrica Announces Pricing of Public Offering of Common Stock
March 22, 2021
From
GlobeNewswire News Releases
Verrica Announces Proposed Public Offering of Common Stock
March 22, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercialize VP-102 For Molluscum and Common Warts in Japan
March 17, 2021
Torii to make upfront payment of $11.5 million to Verrica in addition to other potential milestone payments of up to $58 million and, if marketed in Japan, tiered transfer price payments as a...
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results
March 04, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
March 03, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
February 23, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
February 17, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Confer
January 19, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
December 23, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum
November 17, 2020
- Verrica reaffirms expectation to resubmit its New Drug Application for VP-102 for the treatment of molluscum in the first quarter of 2021 -
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual London Healthcare Conference
November 12, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)
November 10, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 09, 2020
From
GlobeNewswire News Releases
Gore Range Capital Bolsters Advisory Board for Skin Health Investments
October 13, 2020
Gore Range Capital adds world-class advisory board members to new skin health venture capital fund
From
Business Wire News Releases
JAMA Dermatology Publishes Results from Verrica’s Two Pivotal Phase III CAMP (Cantharidin Application in Molluscum Patients) Trials
September 23, 2020
From
GlobeNewswire News Releases
Novan Inc. and Verrica Pharmaceuticals Participate in Virtual Panel to Discuss Developing Treatments for Molluscum Contagiosum on SNN Network
September 22, 2020
From
ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
September 14, 2020
From
PR Newswire
VRCA Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020
September 14, 2020
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA)...
From
PR Newswire
DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
September 14, 2020
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Verrica Pharmaceuticals Inc.
From
Business Wire News Releases
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
September 11, 2020
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 14, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Verrica...
From
Business Wire News Releases
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
September 10, 2020
Law Offices of Howard G. Smith reminds investors of the upcoming September 14, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Verrica...
From
PR Newswire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
September 09, 2020
From
GlobeNewswire News Releases
VRCA Class Action Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020
September 09, 2020
From
GlobeNewswire News Releases
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
September 09, 2020
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 14, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Verrica Pharmaceuticals Inc....
From
PR Newswire
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020
From
GlobeNewswire News Releases
Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm
September 08, 2020
From
NewMediaWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
September 07, 2020
Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA). Such investors are advised to contact Robert S. Willoughby at...
From
PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
September 06, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.